Chemo-Pharma [CPL] vs Escorts Kubota [ESCORTS] Detailed Stock Comparison
Chemo-Pharma
BSE
Loading...
Escorts Kubota
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Chemo-Pharma wins in 7 metrics, Escorts Kubota wins in 12 metrics, with 0 ties. Escorts Kubota appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Chemo-Pharma | Escorts Kubota | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 11.95 | 33.03 | Chemo-Pharma |
| Price-to-Book Ratio | 2.52 | 3.99 | Chemo-Pharma |
| Debt-to-Equity Ratio | 44.70 | 1.02 | Escorts Kubota |
| PEG Ratio | 0.61 | 0.09 | Escorts Kubota |
| EV/EBITDA | 13.68 | 33.69 | Chemo-Pharma |
| Profit Margin (TTM) | 11.11% | 23.21% | Escorts Kubota |
| Operating Margin (TTM) | 9.62% | 10.47% | Escorts Kubota |
| EBITDA Margin (TTM) | 9.62% | 10.47% | Escorts Kubota |
| Return on Equity | 20.97% | 12.21% | Chemo-Pharma |
| Return on Assets (TTM) | 11.26% | 9.66% | Chemo-Pharma |
| Free Cash Flow (TTM) | $41.66M | $7.47B | Escorts Kubota |
| Dividend Yield | N/A | 1.38% | N/A |
| 1-Year Return | -11.43% | -1.19% | Escorts Kubota |
| Price-to-Sales Ratio (TTM) | 1.39 | 4.00 | Chemo-Pharma |
| Enterprise Value | $4.59B | $381.36B | Escorts Kubota |
| EV/Revenue Ratio | 1.57 | 3.75 | Chemo-Pharma |
| Gross Profit Margin (TTM) | 29.30% | 30.87% | Escorts Kubota |
| Revenue per Share (TTM) | $51 | $925 | Escorts Kubota |
| Earnings per Share (Diluted) | $5.66 | $111.82 | Escorts Kubota |
| Beta (Stock Volatility) | 0.23 | 0.14 | Escorts Kubota |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Chemo-Pharma vs Escorts Kubota Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Chemo-Pharma | 0.43% | -0.38% | -7.64% | -11.83% | -19.75% | -42.01% |
| Escorts Kubota | -2.38% | 3.20% | 11.87% | 14.57% | 28.50% | 14.18% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Chemo-Pharma | -11.43% | 282.10% | 118.96% | 724.45% | 1,217.19% | 1,217.19% |
| Escorts Kubota | -1.19% | 95.20% | 204.15% | 2,302.55% | 1,685.40% | 3,373.67% |
News Based Sentiment: Chemo-Pharma vs Escorts Kubota
Chemo-Pharma
News based Sentiment: NEGATIVE
The significant financial losses reported in Q1 FY26, coupled with underperformance relative to the Sensex, create a concerning picture for investors. While the diversification strategy is a positive development, it doesn't immediately offset the current challenges. The volatile stock price and fluctuating investor participation add to the uncertainty.
Escorts Kubota
News based Sentiment: MIXED
Escorts Kubota experienced a significant positive impact from GST cuts, driving a surge in share price. However, this was counterbalanced by a downgrade from Nuvama, a 'Sell' signal from technical analysis, and mixed analyst ratings, creating a complex investment picture. The company's proactive engagement with digital marketplaces and new product launches adds further layers to the narrative.
Performance & Financial Health Analysis: Chemo-Pharma vs Escorts Kubota
| Metric | CPL | ESCORTS |
|---|---|---|
| Market Information | ||
| Market Cap | ₹4.05B | ₹414.42B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 32,878 | 363,264 |
| 90 Day Avg. Volume | 33,955 | 206,614 |
| Last Close | ₹67.73 | ₹3,677.70 |
| 52 Week Range | ₹66.00 - ₹128.00 | ₹2,776.40 - ₹4,420.00 |
| % from 52W High | -47.09% | -16.79% |
| All-Time High | ₹128.00 (Jan 06, 2025) | ₹4,420.00 (Sep 23, 2024) |
| % from All-Time High | -47.09% | -16.79% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.08% | 0.08% |
| Quarterly Earnings Growth | 0.34% | 3.77% |
| Financial Health | ||
| Profit Margin (TTM) | 0.11% | 0.23% |
| Operating Margin (TTM) | 0.10% | 0.10% |
| Return on Equity (TTM) | 0.21% | 0.12% |
| Debt to Equity (MRQ) | 44.70 | 1.02 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹26.86 | ₹926.62 |
| Cash per Share (MRQ) | ₹1.01 | ₹290.87 |
| Operating Cash Flow (TTM) | ₹277.99M | ₹12.38B |
| Levered Free Cash Flow (TTM) | ₹313.23M | ₹12.65B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.38% |
| Last 12-Month Dividend | ₹0.00 | ₹46.00 |
Valuation & Enterprise Metrics Analysis: Chemo-Pharma vs Escorts Kubota
| Metric | CPL | ESCORTS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 11.95 | 33.03 |
| Forward P/E | N/A | 30.56 |
| PEG Ratio | 0.61 | 0.09 |
| Price to Sales (TTM) | 1.39 | 4.00 |
| Price to Book (MRQ) | 2.52 | 3.99 |
| Market Capitalization | ||
| Market Capitalization | ₹4.05B | ₹414.42B |
| Enterprise Value | ₹4.59B | ₹381.36B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.57 | 3.75 |
| Enterprise to EBITDA | 13.68 | 33.69 |
| Risk & Other Metrics | ||
| Beta | 0.23 | 0.14 |
| Book Value per Share (MRQ) | ₹26.86 | ₹926.62 |
Financial Statements Comparison: Chemo-Pharma vs Escorts Kubota
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CPL | ESCORTS |
|---|---|---|
| Revenue/Sales | ₹697.42M | ₹25.00B |
| Cost of Goods Sold | ₹493.08M | ₹17.28B |
| Gross Profit | ₹204.34M | ₹7.72B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹67.12M | ₹2.62B |
| EBITDA | ₹79.31M | ₹4.78B |
| Pre-Tax Income | ₹55.13M | ₹4.90B |
| Income Tax | ₹12.13M | ₹1.20B |
| Net Income (Profit) | ₹42.99M | ₹13.97B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CPL | ESCORTS |
|---|---|---|
| Cash & Equivalents | ₹12.05M | ₹3.43B |
| Total Current Assets | ₹2.51B | ₹71.35B |
| Total Current Liabilities | ₹1.17B | ₹24.88B |
| Long-Term Debt | ₹109.50M | ₹677.40M |
| Total Shareholders Equity | ₹1.49B | ₹103.63B |
| Retained Earnings | N/A | ₹60.72B |
| Property, Plant & Equipment | ₹144.04M | ₹19.81B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CPL | ESCORTS |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CPL | ESCORTS |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 32,878 | 363,264 |
| Average Daily Volume (90 Day) | 33,955 | 206,614 |
| Shares Outstanding | 57.55M | 110.00M |
| Float Shares | 17.06M | 31.53M |
| % Held by Insiders | 0.70% | 0.73% |
| % Held by Institutions | 0.00% | 0.13% |
Dividend Analysis & Yield Comparison: Chemo-Pharma vs Escorts Kubota
| Metric | CPL | ESCORTS |
|---|---|---|
| Last 12-Month Dividend | ₹0.00 | ₹46.00 |
| Last 12-Month Dividend Yield | N/A | 1.38% |
| 3-Year Avg Annual Dividend | ₹0.00 | ₹17.67 |
| 3-Year Avg Dividend Yield | N/A | 0.41% |
| 3-Year Total Dividends | ₹0.00 | ₹53.00 |
| Ex-Dividend Date | N/A | Jul 04, 2025 |